FNDC5 and sarcopenia: (115) found that there was no difference in plasma irisin levels between patients with aging sarcopenia and healthy older individuals, and even an increase in blood irisin levels could not change the state of reduced muscle mass, muscle dysfunction, and physical performance in patients with aging sarcopenia.